

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 5.76679933 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.76679933 |
| 3 | intestinal absorption (GO:0050892) | 4.99735911 |
| 4 | intestinal cholesterol absorption (GO:0030299) | 4.87399659 |
| 5 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.68791645 |
| 6 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.64376165 |
| 7 | protein retention in ER lumen (GO:0006621) | 4.58025504 |
| 8 | sulfur amino acid catabolic process (GO:0000098) | 4.56679154 |
| 9 | GDP-mannose metabolic process (GO:0019673) | 4.55643608 |
| 10 | nucleotide-sugar biosynthetic process (GO:0009226) | 4.51003820 |
| 11 | intestinal epithelial cell development (GO:0060576) | 4.13405997 |
| 12 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.11855530 |
| 13 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.11855530 |
| 14 | COPII vesicle coating (GO:0048208) | 3.93779203 |
| 15 | proteasome assembly (GO:0043248) | 3.82343934 |
| 16 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.74554684 |
| 17 | proline biosynthetic process (GO:0006561) | 3.73658374 |
| 18 | 4-hydroxyproline metabolic process (GO:0019471) | 3.67997984 |
| 19 | nucleotide-sugar metabolic process (GO:0009225) | 3.59930338 |
| 20 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.58161140 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.51953061 |
| 22 | L-phenylalanine metabolic process (GO:0006558) | 3.51953061 |
| 23 | regulation of mitochondrial translation (GO:0070129) | 3.51292821 |
| 24 | desmosome organization (GO:0002934) | 3.47558405 |
| 25 | bile acid and bile salt transport (GO:0015721) | 3.46848867 |
| 26 | transcytosis (GO:0045056) | 3.35239019 |
| 27 | protein autoprocessing (GO:0016540) | 3.35115061 |
| 28 | regulation of cholesterol homeostasis (GO:2000188) | 3.30590996 |
| 29 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.28087794 |
| 30 | L-serine metabolic process (GO:0006563) | 3.26859805 |
| 31 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.25207672 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.24794222 |
| 33 | L-phenylalanine catabolic process (GO:0006559) | 3.24794222 |
| 34 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.20576050 |
| 35 | negative regulation of sterol transport (GO:0032372) | 3.16646571 |
| 36 | negative regulation of cholesterol transport (GO:0032375) | 3.16646571 |
| 37 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.14351345 |
| 38 | oxidative phosphorylation (GO:0006119) | 3.13381826 |
| 39 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.13115739 |
| 40 | signal peptide processing (GO:0006465) | 3.13007833 |
| 41 | primary alcohol catabolic process (GO:0034310) | 3.11905602 |
| 42 | proline metabolic process (GO:0006560) | 3.09501494 |
| 43 | nucleotide salvage (GO:0043173) | 3.08962901 |
| 44 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.08334289 |
| 45 | protein maturation by protein folding (GO:0022417) | 3.07820339 |
| 46 | nuclear envelope reassembly (GO:0031468) | 3.06941437 |
| 47 | mitotic nuclear envelope reassembly (GO:0007084) | 3.06941437 |
| 48 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.06719605 |
| 49 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 3.05895564 |
| 50 | nucleoside bisphosphate metabolic process (GO:0033865) | 3.05895564 |
| 51 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 3.05895564 |
| 52 | homocysteine metabolic process (GO:0050667) | 3.05628303 |
| 53 | cysteine metabolic process (GO:0006534) | 3.05396849 |
| 54 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.04395801 |
| 55 | cellular glucuronidation (GO:0052695) | 3.01276937 |
| 56 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.99872084 |
| 57 | high-density lipoprotein particle remodeling (GO:0034375) | 2.99305884 |
| 58 | ethanol metabolic process (GO:0006067) | 2.98326543 |
| 59 | alpha-linolenic acid metabolic process (GO:0036109) | 2.98000245 |
| 60 | triglyceride homeostasis (GO:0070328) | 2.97342713 |
| 61 | acylglycerol homeostasis (GO:0055090) | 2.97342713 |
| 62 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.96727103 |
| 63 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.96689940 |
| 64 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.96503103 |
| 65 | negative regulation of ligase activity (GO:0051352) | 2.93439835 |
| 66 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.93439835 |
| 67 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.93104683 |
| 68 | serine family amino acid biosynthetic process (GO:0009070) | 2.91519772 |
| 69 | positive regulation of nuclease activity (GO:0032075) | 2.89841189 |
| 70 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.89153526 |
| 71 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.88035117 |
| 72 | purine nucleotide salvage (GO:0032261) | 2.87807712 |
| 73 | cellular ketone body metabolic process (GO:0046950) | 2.86818069 |
| 74 | nucleoside salvage (GO:0043174) | 2.86628846 |
| 75 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.86334536 |
| 76 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.86161039 |
| 77 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.85971545 |
| 78 | pentose-phosphate shunt (GO:0006098) | 2.84479482 |
| 79 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.82899099 |
| 80 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.80480149 |
| 81 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.80480149 |
| 82 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.80264094 |
| 83 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.80264094 |
| 84 | glucose 6-phosphate metabolic process (GO:0051156) | 2.79680948 |
| 85 | endocrine pancreas development (GO:0031018) | 2.77867542 |
| 86 | uronic acid metabolic process (GO:0006063) | 2.77545025 |
| 87 | glucuronate metabolic process (GO:0019585) | 2.77545025 |
| 88 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.76589199 |
| 89 | regulation of triglyceride catabolic process (GO:0010896) | 2.76363987 |
| 90 | tricarboxylic acid cycle (GO:0006099) | 2.76124948 |
| 91 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.76106721 |
| 92 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.76106721 |
| 93 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.76106721 |
| 94 | mitochondrial calcium ion transport (GO:0006851) | 2.75925778 |
| 95 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.75365753 |
| 96 | reverse cholesterol transport (GO:0043691) | 2.75351078 |
| 97 | flavonoid metabolic process (GO:0009812) | 2.73150160 |
| 98 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.73136492 |
| 99 | phospholipid efflux (GO:0033700) | 2.72805416 |
| 100 | digestive system process (GO:0022600) | 2.72109433 |
| 101 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.72051713 |
| 102 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.72051713 |
| 103 | drug catabolic process (GO:0042737) | 2.69637776 |
| 104 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.68457103 |
| 105 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.67953356 |
| 106 | establishment of viral latency (GO:0019043) | 2.67153917 |
| 107 | aromatic amino acid family catabolic process (GO:0009074) | 2.66821681 |
| 108 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.66778780 |
| 109 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.66218327 |
| 110 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.66218327 |
| 111 | lipoprotein metabolic process (GO:0042157) | 2.66199646 |
| 112 | digestion (GO:0007586) | 2.66149421 |
| 113 | regulation of translational fidelity (GO:0006450) | 2.65628179 |
| 114 | regulation of nuclease activity (GO:0032069) | 2.65002498 |
| 115 | establishment of integrated proviral latency (GO:0075713) | 2.63384279 |
| 116 | DNA strand elongation (GO:0022616) | 2.63257095 |
| 117 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 2.62703257 |
| 118 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 2.62703257 |
| 119 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 2.62703257 |
| 120 | plasma lipoprotein particle remodeling (GO:0034369) | 2.62641721 |
| 121 | protein-lipid complex remodeling (GO:0034368) | 2.62641721 |
| 122 | macromolecular complex remodeling (GO:0034367) | 2.62641721 |
| 123 | regulation of metalloenzyme activity (GO:0048552) | 2.62183144 |
| 124 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.61559076 |
| 125 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.61183319 |
| 126 | NADPH regeneration (GO:0006740) | 2.60886406 |
| 127 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.60042824 |
| 128 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.59559638 |
| 129 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.57976558 |
| 130 | valine metabolic process (GO:0006573) | 2.57671054 |
| 131 | lysine metabolic process (GO:0006553) | 2.57306009 |
| 132 | lysine catabolic process (GO:0006554) | 2.57306009 |
| 133 | fatty acid beta-oxidation (GO:0006635) | 2.57279943 |
| 134 | positive regulation of ligase activity (GO:0051351) | 2.56863615 |
| 135 | glutathione biosynthetic process (GO:0006750) | 2.56795116 |
| 136 | plasma lipoprotein particle assembly (GO:0034377) | 2.56283713 |
| 137 | peptidyl-asparagine modification (GO:0018196) | 2.55293860 |
| 138 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.55023950 |
| 139 | NADH metabolic process (GO:0006734) | 2.54355987 |
| 140 | regulation of proton transport (GO:0010155) | 2.54116312 |
| 141 | urea cycle (GO:0000050) | 2.53750471 |
| 142 | urea metabolic process (GO:0019627) | 2.53750471 |
| 143 | cellular response to unfolded protein (GO:0034620) | 2.53571064 |
| 144 | pyrimidine-containing compound salvage (GO:0008655) | 2.53435005 |
| 145 | pyrimidine nucleoside salvage (GO:0043097) | 2.53435005 |
| 146 | ribosome biogenesis (GO:0042254) | 2.51682803 |
| 147 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.50453371 |
| 148 | mitochondrial RNA metabolic process (GO:0000959) | 2.49432763 |
| 149 | protein targeting to mitochondrion (GO:0006626) | 2.49001427 |
| 150 | polyketide metabolic process (GO:0030638) | 2.47743918 |
| 151 | doxorubicin metabolic process (GO:0044598) | 2.47743918 |
| 152 | daunorubicin metabolic process (GO:0044597) | 2.47743918 |
| 153 | regulation of cellular amine metabolic process (GO:0033238) | 2.47211704 |
| 154 | tRNA aminoacylation for protein translation (GO:0006418) | 2.46816418 |
| 155 | de novo posttranslational protein folding (GO:0051084) | 2.46732168 |
| 156 | glycosphingolipid catabolic process (GO:0046479) | 2.46135464 |
| 157 | folic acid metabolic process (GO:0046655) | 2.45348952 |
| 158 | gluconeogenesis (GO:0006094) | 2.44990255 |
| 159 | monosaccharide biosynthetic process (GO:0046364) | 2.43567649 |
| 160 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.43442050 |
| 161 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.43410265 |
| 162 | cellular copper ion homeostasis (GO:0006878) | 2.42883109 |
| 163 | glycoside metabolic process (GO:0016137) | 2.40870729 |
| 164 | base-excision repair, AP site formation (GO:0006285) | 2.40294727 |
| 165 | pseudouridine synthesis (GO:0001522) | 2.40039174 |
| 166 | de novo protein folding (GO:0006458) | 2.40031711 |
| 167 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.39317485 |
| 168 | tRNA aminoacylation (GO:0043039) | 2.37628922 |
| 169 | amino acid activation (GO:0043038) | 2.37628922 |
| 170 | rRNA modification (GO:0000154) | 2.37353308 |
| 171 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.36980737 |
| 172 | hexose biosynthetic process (GO:0019319) | 2.36588605 |
| 173 | nucleoside transmembrane transport (GO:1901642) | 2.34431570 |
| 174 | glycolipid catabolic process (GO:0019377) | 2.34223622 |
| 175 | mitochondrial fusion (GO:0008053) | 2.34218518 |
| 176 | alpha-amino acid biosynthetic process (GO:1901607) | 2.32545311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.09713995 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.01696199 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.97324212 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.43677261 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.39888768 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.15612171 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.86811677 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.83534313 |
| 9 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.65219944 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44039572 |
| 11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.25800177 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.25685630 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.20233056 |
| 14 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.12445372 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.10140510 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.07410346 |
| 17 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.95984630 |
| 18 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.91985400 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.90915274 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.90231611 |
| 21 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.86796197 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.83621953 |
| 23 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.81206589 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.77527151 |
| 25 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.74417541 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.73624696 |
| 27 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73041595 |
| 28 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.72794296 |
| 29 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.70277206 |
| 30 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.68118199 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.67721695 |
| 32 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.65457984 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.64217528 |
| 34 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.61726131 |
| 35 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.57300883 |
| 36 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.57034153 |
| 37 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.56580074 |
| 38 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.56017202 |
| 39 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.54258165 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54100318 |
| 41 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.50574734 |
| 42 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.49401766 |
| 43 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.47456827 |
| 44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.46099565 |
| 45 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.43309870 |
| 46 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.42214090 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39791754 |
| 48 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.38337204 |
| 49 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.38155710 |
| 50 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.35959323 |
| 51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.35257016 |
| 52 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.34591643 |
| 53 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.34453630 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33566359 |
| 55 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.33227733 |
| 56 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.32174894 |
| 57 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.30745533 |
| 58 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.29315034 |
| 59 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.28153824 |
| 60 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.24305148 |
| 61 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24263152 |
| 62 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.23810261 |
| 63 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.22598648 |
| 64 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.21893749 |
| 65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20437723 |
| 66 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.20143205 |
| 67 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.19646955 |
| 68 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18388040 |
| 69 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15773162 |
| 70 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.15194811 |
| 71 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.13567657 |
| 72 | P68_20966046_ChIP-Seq_HELA_Human | 1.12832263 |
| 73 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.12437464 |
| 74 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12362745 |
| 75 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.11998321 |
| 76 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.11857204 |
| 77 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.11659056 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11177328 |
| 79 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.09951133 |
| 80 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.08721809 |
| 81 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.08588935 |
| 82 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08069822 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05677434 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04556570 |
| 85 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.04475454 |
| 86 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04371357 |
| 87 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04122907 |
| 88 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.03814349 |
| 89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03556873 |
| 90 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.02991480 |
| 91 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.02720739 |
| 92 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01976916 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01976315 |
| 94 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01697092 |
| 95 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.00801775 |
| 96 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00284050 |
| 97 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.00273450 |
| 98 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.99834123 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.99303703 |
| 100 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98353762 |
| 101 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98314126 |
| 102 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98241811 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98135287 |
| 104 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.98125200 |
| 105 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.97600241 |
| 106 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97131406 |
| 107 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95870360 |
| 108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.95257425 |
| 109 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.95237420 |
| 110 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94913802 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94454174 |
| 112 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.94393410 |
| 113 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.94272020 |
| 114 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.93932423 |
| 115 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.93606254 |
| 116 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93404094 |
| 117 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92601569 |
| 118 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92530453 |
| 119 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.91610338 |
| 120 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90837810 |
| 121 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.90684381 |
| 122 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.88994809 |
| 123 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88666385 |
| 124 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87811425 |
| 125 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87775737 |
| 126 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.87536930 |
| 127 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.87347202 |
| 128 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.86878754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.29170637 |
| 2 | MP0005360_urolithiasis | 4.77437511 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.16228975 |
| 4 | MP0005365_abnormal_bile_salt | 3.80085159 |
| 5 | MP0001666_abnormal_nutrient_absorption | 3.79115942 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.77333711 |
| 7 | MP0004264_abnormal_extraembryonic_tissu | 3.37985616 |
| 8 | MP0005083_abnormal_biliary_tract | 3.00126416 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.97613318 |
| 10 | MP0003283_abnormal_digestive_organ | 2.87347041 |
| 11 | MP0009840_abnormal_foam_cell | 2.47709190 |
| 12 | MP0003693_abnormal_embryo_hatching | 2.40115684 |
| 13 | MP0010030_abnormal_orbit_morphology | 2.37533899 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.28358644 |
| 15 | MP0003252_abnormal_bile_duct | 2.21096040 |
| 16 | MP0000462_abnormal_digestive_system | 2.15157004 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.14510861 |
| 18 | MP0005408_hypopigmentation | 2.14337830 |
| 19 | MP0003866_abnormal_defecation | 2.04202151 |
| 20 | MP0009643_abnormal_urine_homeostasis | 1.80561214 |
| 21 | MP0001873_stomach_inflammation | 1.76603008 |
| 22 | MP0005220_abnormal_exocrine_pancreas | 1.75872254 |
| 23 | MP0003111_abnormal_nucleus_morphology | 1.74988040 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.73183844 |
| 25 | MP0005381_digestive/alimentary_phenotyp | 1.66205308 |
| 26 | MP0005332_abnormal_amino_acid | 1.65527261 |
| 27 | MP0001663_abnormal_digestive_system | 1.63792253 |
| 28 | MP0008932_abnormal_embryonic_tissue | 1.61525171 |
| 29 | MP0003786_premature_aging | 1.61307960 |
| 30 | MP0001664_abnormal_digestion | 1.57469076 |
| 31 | MP0005257_abnormal_intraocular_pressure | 1.54511097 |
| 32 | MP0003868_abnormal_feces_composition | 1.54384346 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.54120651 |
| 34 | MP0000609_abnormal_liver_physiology | 1.52883973 |
| 35 | MP0002098_abnormal_vibrissa_morphology | 1.50729879 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.50719771 |
| 37 | MP0002796_impaired_skin_barrier | 1.50535997 |
| 38 | MP0000490_abnormal_crypts_of | 1.44905737 |
| 39 | MP0005084_abnormal_gallbladder_morpholo | 1.44113767 |
| 40 | MP0001764_abnormal_homeostasis | 1.43641305 |
| 41 | MP0004019_abnormal_vitamin_homeostasis | 1.43037230 |
| 42 | MP0000477_abnormal_intestine_morphology | 1.42550363 |
| 43 | MP0000358_abnormal_cell_content/ | 1.41675281 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 1.41622723 |
| 45 | MP0002909_abnormal_adrenal_gland | 1.40960471 |
| 46 | MP0003077_abnormal_cell_cycle | 1.40195417 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.39526839 |
| 48 | MP0004272_abnormal_basement_membrane | 1.39452676 |
| 49 | MP0002118_abnormal_lipid_homeostasis | 1.38634594 |
| 50 | MP0010094_abnormal_chromosome_stability | 1.37416550 |
| 51 | MP0006054_spinal_hemorrhage | 1.37109215 |
| 52 | MP0005319_abnormal_enzyme/_coenzyme | 1.36733182 |
| 53 | MP0005451_abnormal_body_composition | 1.35888361 |
| 54 | MP0008058_abnormal_DNA_repair | 1.35576677 |
| 55 | MP0008007_abnormal_cellular_replicative | 1.35367173 |
| 56 | MP0008004_abnormal_stomach_pH | 1.34903865 |
| 57 | MP0003186_abnormal_redox_activity | 1.33381861 |
| 58 | MP0010352_gastrointestinal_tract_polyps | 1.30338327 |
| 59 | MP0000566_synostosis | 1.27525276 |
| 60 | MP0004957_abnormal_blastocyst_morpholog | 1.25544484 |
| 61 | MP0001944_abnormal_pancreas_morphology | 1.23206924 |
| 62 | MP0004043_abnormal_pH_regulation | 1.23130351 |
| 63 | MP0003315_abnormal_perineum_morphology | 1.22880012 |
| 64 | MP0008260_abnormal_autophagy | 1.22126232 |
| 65 | MP0000537_abnormal_urethra_morphology | 1.20399128 |
| 66 | MP0002693_abnormal_pancreas_physiology | 1.18913225 |
| 67 | MP0004233_abnormal_muscle_weight | 1.17079327 |
| 68 | MP0001661_extended_life_span | 1.16893903 |
| 69 | MP0006036_abnormal_mitochondrial_physio | 1.15027583 |
| 70 | MP0000678_abnormal_parathyroid_gland | 1.14068030 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 1.13145555 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 1.10779796 |
| 73 | MP0003950_abnormal_plasma_membrane | 1.06456539 |
| 74 | MP0002938_white_spotting | 1.06177222 |
| 75 | MP0003718_maternal_effect | 1.05535541 |
| 76 | MP0006035_abnormal_mitochondrial_morpho | 1.04728206 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.04441350 |
| 78 | MP0001727_abnormal_embryo_implantation | 1.03763415 |
| 79 | MP0001730_embryonic_growth_arrest | 1.03541096 |
| 80 | MP0001881_abnormal_mammary_gland | 1.02003613 |
| 81 | MP0003123_paternal_imprinting | 1.01792321 |
| 82 | MP0005501_abnormal_skin_physiology | 1.01747641 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.99788537 |
| 84 | MP0005058_abnormal_lysosome_morphology | 0.98608221 |
| 85 | MP0005670_abnormal_white_adipose | 0.98238703 |
| 86 | MP0001756_abnormal_urination | 0.98061900 |
| 87 | MP0000013_abnormal_adipose_tissue | 0.94905589 |
| 88 | MP0000516_abnormal_urinary_system | 0.93420751 |
| 89 | MP0005367_renal/urinary_system_phenotyp | 0.93420751 |
| 90 | MP0002060_abnormal_skin_morphology | 0.93019463 |
| 91 | MP0000538_abnormal_urinary_bladder | 0.92989850 |
| 92 | MP0003195_calcinosis | 0.91902237 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 0.91238784 |
| 94 | MP0010771_integument_phenotype | 0.90925791 |
| 95 | MP0000762_abnormal_tongue_morphology | 0.90837943 |
| 96 | MP0000598_abnormal_liver_morphology | 0.90817035 |
| 97 | MP0000647_abnormal_sebaceous_gland | 0.90497403 |
| 98 | MP0002877_abnormal_melanocyte_morpholog | 0.90224250 |
| 99 | MP0003878_abnormal_ear_physiology | 0.88492584 |
| 100 | MP0005377_hearing/vestibular/ear_phenot | 0.88492584 |
| 101 | MP0001765_abnormal_ion_homeostasis | 0.86127853 |
| 102 | MP0005165_increased_susceptibility_to | 0.85018641 |
| 103 | MP0002080_prenatal_lethality | 0.84756796 |
| 104 | MP0009780_abnormal_chondrocyte_physiolo | 0.84272801 |
| 105 | MP0002876_abnormal_thyroid_physiology | 0.83273033 |
| 106 | MP0004185_abnormal_adipocyte_glucose | 0.82031086 |
| 107 | MP0005410_abnormal_fertilization | 0.80566448 |
| 108 | MP0001216_abnormal_epidermal_layer | 0.79964325 |
| 109 | MP0009384_cardiac_valve_regurgitation | 0.78343821 |
| 110 | MP0000858_altered_metastatic_potential | 0.77319245 |
| 111 | MP0005266_abnormal_metabolism | 0.76737639 |
| 112 | MP0002896_abnormal_bone_mineralization | 0.75990213 |
| 113 | MP0004858_abnormal_nervous_system | 0.75156380 |
| 114 | MP0000003_abnormal_adipose_tissue | 0.73742896 |
| 115 | MP0005448_abnormal_energy_balance | 0.73649601 |
| 116 | MP0009642_abnormal_blood_homeostasis | 0.73629168 |
| 117 | MP0001243_abnormal_dermal_layer | 0.72710778 |
| 118 | MP0003453_abnormal_keratinocyte_physiol | 0.72522885 |
| 119 | MP0001849_ear_inflammation | 0.71977808 |
| 120 | MP0000470_abnormal_stomach_morphology | 0.71944529 |
| 121 | MP0004947_skin_inflammation | 0.71331081 |
| 122 | MP0000015_abnormal_ear_pigmentation | 0.71138879 |
| 123 | MP0000163_abnormal_cartilage_morphology | 0.70151153 |
| 124 | MP0010678_abnormal_skin_adnexa | 0.67864170 |
| 125 | MP0009379_abnormal_foot_pigmentation | 0.67609304 |
| 126 | MP0005023_abnormal_wound_healing | 0.67597833 |
| 127 | MP0005376_homeostasis/metabolism_phenot | 0.67350836 |
| 128 | MP0005395_other_phenotype | 0.67180753 |
| 129 | MP0005330_cardiomyopathy | 0.67120808 |
| 130 | MP0005197_abnormal_uvea_morphology | 0.66805087 |
| 131 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66523905 |
| 132 | MP0001697_abnormal_embryo_size | 0.66197067 |
| 133 | MP0002132_abnormal_respiratory_system | 0.66133766 |
| 134 | MP0003183_abnormal_peptide_metabolism | 0.65676021 |
| 135 | MP0009931_abnormal_skin_appearance | 0.64652339 |
| 136 | MP0005380_embryogenesis_phenotype | 0.64074783 |
| 137 | MP0001672_abnormal_embryogenesis/_devel | 0.64074783 |
| 138 | MP0000627_abnormal_mammary_gland | 0.63954366 |
| 139 | MP0003436_decreased_susceptibility_to | 0.63914501 |
| 140 | MP0009697_abnormal_copulation | 0.63845410 |
| 141 | MP0002136_abnormal_kidney_physiology | 0.63754272 |
| 142 | MP0002933_joint_inflammation | 0.63152185 |
| 143 | MP0000367_abnormal_coat/_hair | 0.62770310 |
| 144 | MP0000467_abnormal_esophagus_morphology | 0.61930749 |
| 145 | MP0004147_increased_porphyrin_level | 0.61504387 |
| 146 | MP0008469_abnormal_protein_level | 0.61441991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal tarsal ossification (HP:0008369) | 5.14068441 |
| 2 | Irregular epiphyses (HP:0010582) | 4.38605406 |
| 3 | Hypoglycemic coma (HP:0001325) | 4.33166883 |
| 4 | Flat acetabular roof (HP:0003180) | 3.72150877 |
| 5 | Cupped ribs (HP:0000887) | 3.71806734 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 3.71109705 |
| 7 | Abnormal foot bone ossification (HP:0010675) | 3.70738301 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.60904368 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 3.55265771 |
| 10 | Abnormality of glycolysis (HP:0004366) | 3.53867938 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.51992896 |
| 12 | Abnormal gallbladder physiology (HP:0012438) | 3.49924927 |
| 13 | Cholecystitis (HP:0001082) | 3.49924927 |
| 14 | Flat capital femoral epiphysis (HP:0003370) | 3.42058171 |
| 15 | Symptomatic seizures (HP:0011145) | 3.32620399 |
| 16 | Ileus (HP:0002595) | 3.29706867 |
| 17 | Abdominal distention (HP:0003270) | 3.26661693 |
| 18 | Hypoglycemic seizures (HP:0002173) | 3.21512561 |
| 19 | Increased serum pyruvate (HP:0003542) | 3.21163918 |
| 20 | Epiphyseal dysplasia (HP:0002656) | 3.19142838 |
| 21 | Delayed epiphyseal ossification (HP:0002663) | 3.10498060 |
| 22 | Xanthomatosis (HP:0000991) | 3.05715107 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.93236976 |
| 24 | Dicarboxylic aciduria (HP:0003215) | 2.92104727 |
| 25 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.92104727 |
| 26 | Hepatocellular necrosis (HP:0001404) | 2.90112035 |
| 27 | Protuberant abdomen (HP:0001538) | 2.85875871 |
| 28 | Malnutrition (HP:0004395) | 2.83228726 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 2.82703438 |
| 30 | Flattened epiphyses (HP:0003071) | 2.82628159 |
| 31 | Late onset (HP:0003584) | 2.80629314 |
| 32 | Abnormality of carpal bone ossification (HP:0006257) | 2.78446267 |
| 33 | Right ventricular cardiomyopathy (HP:0011663) | 2.77509298 |
| 34 | Generalized aminoaciduria (HP:0002909) | 2.77253564 |
| 35 | Beaking of vertebral bodies (HP:0004568) | 2.74226944 |
| 36 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.74196604 |
| 37 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.72803152 |
| 38 | Hypokinesia (HP:0002375) | 2.70580318 |
| 39 | Fat malabsorption (HP:0002630) | 2.68961646 |
| 40 | Abnormal cartilage morphology (HP:0002763) | 2.66702212 |
| 41 | Genu varum (HP:0002970) | 2.64854051 |
| 42 | Hypolipoproteinemia (HP:0010981) | 2.61938135 |
| 43 | Abnormality of alanine metabolism (HP:0010916) | 2.60397274 |
| 44 | Hyperalaninemia (HP:0003348) | 2.60397274 |
| 45 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.60397274 |
| 46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.56182152 |
| 47 | Hyperammonemia (HP:0001987) | 2.55992387 |
| 48 | Small epiphyses (HP:0010585) | 2.54786571 |
| 49 | Rough bone trabeculation (HP:0100670) | 2.51853618 |
| 50 | Conjugated hyperbilirubinemia (HP:0002908) | 2.51562891 |
| 51 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.50276877 |
| 52 | Abnormality of proline metabolism (HP:0010907) | 2.46927694 |
| 53 | Hydroxyprolinuria (HP:0003080) | 2.46927694 |
| 54 | Entropion (HP:0000621) | 2.46520782 |
| 55 | Glomerulosclerosis (HP:0000096) | 2.46244010 |
| 56 | Irregular vertebral endplates (HP:0003301) | 2.45838814 |
| 57 | Hyperglycinuria (HP:0003108) | 2.45801769 |
| 58 | Poikiloderma (HP:0001029) | 2.44850450 |
| 59 | Hepatic necrosis (HP:0002605) | 2.44197246 |
| 60 | Ketoacidosis (HP:0001993) | 2.42786037 |
| 61 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.41933932 |
| 62 | Acute necrotizing encephalopathy (HP:0006965) | 2.41888545 |
| 63 | Upper limb muscle weakness (HP:0003484) | 2.41067259 |
| 64 | Reduced antithrombin III activity (HP:0001976) | 2.39030948 |
| 65 | Upper limb amyotrophy (HP:0009129) | 2.38235662 |
| 66 | Distal upper limb amyotrophy (HP:0007149) | 2.38235662 |
| 67 | Ketosis (HP:0001946) | 2.36054258 |
| 68 | Increased serum lactate (HP:0002151) | 2.35547297 |
| 69 | Vertebral clefting (HP:0008428) | 2.34519936 |
| 70 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.34497235 |
| 71 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.34497235 |
| 72 | Abnormal trabecular bone morphology (HP:0100671) | 2.28821727 |
| 73 | Microretrognathia (HP:0000308) | 2.28447377 |
| 74 | Increased CSF lactate (HP:0002490) | 2.27839902 |
| 75 | Mitochondrial inheritance (HP:0001427) | 2.26795331 |
| 76 | Focal segmental glomerulosclerosis (HP:0000097) | 2.26519964 |
| 77 | Metaphyseal irregularity (HP:0003025) | 2.26139120 |
| 78 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.25675019 |
| 79 | Abnormal hair laboratory examination (HP:0003328) | 2.24735794 |
| 80 | Abnormality of the vertebral endplates (HP:0005106) | 2.23111430 |
| 81 | Lactic acidosis (HP:0003128) | 2.21925042 |
| 82 | Delayed CNS myelination (HP:0002188) | 2.21857846 |
| 83 | Deep venous thrombosis (HP:0002625) | 2.21140132 |
| 84 | Prolonged neonatal jaundice (HP:0006579) | 2.19769687 |
| 85 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.18781702 |
| 86 | Abnormality of femoral epiphyses (HP:0006499) | 2.18432554 |
| 87 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 2.18432554 |
| 88 | Vitreoretinal degeneration (HP:0000655) | 2.14888628 |
| 89 | Lethargy (HP:0001254) | 2.14671598 |
| 90 | Cerebral edema (HP:0002181) | 2.13747187 |
| 91 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 2.13522340 |
| 92 | Nonimmune hydrops fetalis (HP:0001790) | 2.13141661 |
| 93 | Vertebral compression fractures (HP:0002953) | 2.12920390 |
| 94 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.12833378 |
| 95 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.12301292 |
| 96 | Testicular atrophy (HP:0000029) | 2.11849239 |
| 97 | Abnormality of the common coagulation pathway (HP:0010990) | 2.11600921 |
| 98 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.11279877 |
| 99 | Metaphyseal cupping (HP:0003021) | 2.11076064 |
| 100 | Vascular calcification (HP:0004934) | 2.09605264 |
| 101 | Hand muscle atrophy (HP:0009130) | 2.09324623 |
| 102 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.08600945 |
| 103 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.08600945 |
| 104 | Abnormal protein glycosylation (HP:0012346) | 2.08600945 |
| 105 | Abnormal glycosylation (HP:0012345) | 2.08600945 |
| 106 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.08294545 |
| 107 | Abnormality of the umbilical cord (HP:0010881) | 2.07338842 |
| 108 | Spastic paraparesis (HP:0002313) | 2.06403403 |
| 109 | Abnormal hand bone ossification (HP:0010660) | 2.05958284 |
| 110 | Hyperbilirubinemia (HP:0002904) | 2.05525433 |
| 111 | Abnormal ossification of hand bones (HP:0005921) | 2.05085099 |
| 112 | Abnormality of glycine metabolism (HP:0010895) | 2.03484632 |
| 113 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.03484632 |
| 114 | Trismus (HP:0000211) | 2.01970959 |
| 115 | Type I transferrin isoform profile (HP:0003642) | 2.01868682 |
| 116 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.99943683 |
| 117 | Short femoral neck (HP:0100864) | 1.98105095 |
| 118 | Proximal tubulopathy (HP:0000114) | 1.97926934 |
| 119 | Carpal bone hypoplasia (HP:0001498) | 1.97286478 |
| 120 | Prolonged partial thromboplastin time (HP:0003645) | 1.96010574 |
| 121 | Hypoalphalipoproteinemia (HP:0003233) | 1.95691562 |
| 122 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.95598658 |
| 123 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.95598658 |
| 124 | Abnormality of glycolipid metabolism (HP:0010969) | 1.95598658 |
| 125 | Hyperglycinemia (HP:0002154) | 1.95368198 |
| 126 | Hyperglycemia (HP:0003074) | 1.94459675 |
| 127 | Abnormality of the femoral head (HP:0003368) | 1.94336177 |
| 128 | Acute encephalopathy (HP:0006846) | 1.94231968 |
| 129 | Abnormality of the Achilles tendon (HP:0005109) | 1.93304678 |
| 130 | Ragged-red muscle fibers (HP:0003200) | 1.92370737 |
| 131 | Glycosuria (HP:0003076) | 1.91935834 |
| 132 | Abnormality of urine glucose concentration (HP:0011016) | 1.91935834 |
| 133 | Sparse eyelashes (HP:0000653) | 1.91911095 |
| 134 | Achilles tendon contracture (HP:0001771) | 1.91821754 |
| 135 | Abnormality of purine metabolism (HP:0004352) | 1.91017303 |
| 136 | Pili torti (HP:0003777) | 1.90566102 |
| 137 | Platyspondyly (HP:0000926) | 1.89952122 |
| 138 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.88686493 |
| 139 | Abnormal epiphyseal ossification (HP:0010656) | 1.88633249 |
| 140 | Hyperparathyroidism (HP:0000843) | 1.87758721 |
| 141 | Insulin resistance (HP:0000855) | 1.87631567 |
| 142 | Abnormal pancreas size (HP:0012094) | 1.86556290 |
| 143 | Exercise intolerance (HP:0003546) | 1.85098722 |
| 144 | Myopathic facies (HP:0002058) | 1.84342010 |
| 145 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.83823890 |
| 146 | Paraparesis (HP:0002385) | 1.83753924 |
| 147 | Hemorrhage of the eye (HP:0011885) | 1.83683427 |
| 148 | Opisthotonus (HP:0002179) | 1.83573934 |
| 149 | Increased purine levels (HP:0004368) | 1.83461208 |
| 150 | Hyperuricemia (HP:0002149) | 1.83461208 |
| 151 | Spinal cord compression (HP:0002176) | 1.83022343 |
| 152 | Nausea (HP:0002018) | 1.82628412 |
| 153 | Palpitations (HP:0001962) | 1.80707180 |
| 154 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.80705308 |
| 155 | CNS demyelination (HP:0007305) | 1.80467115 |
| 156 | Gout (HP:0001997) | 1.80337696 |
| 157 | Vacuolated lymphocytes (HP:0001922) | 1.80327192 |
| 158 | Distal lower limb amyotrophy (HP:0008944) | 1.79874030 |
| 159 | Abnormality of methionine metabolism (HP:0010901) | 1.78465558 |
| 160 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.77831267 |
| 161 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.77831267 |
| 162 | Osteoarthritis (HP:0002758) | 1.77452350 |
| 163 | Abnormality of nucleobase metabolism (HP:0010932) | 1.76975361 |
| 164 | Squamous cell carcinoma (HP:0002860) | 1.76261991 |
| 165 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.75126090 |
| 166 | Short nail (HP:0001799) | 1.74943648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 4.07202676 |
| 2 | ERN1 | 3.92285672 |
| 3 | BCKDK | 3.34877018 |
| 4 | MAP2K2 | 3.06895663 |
| 5 | NME1 | 2.71823070 |
| 6 | EPHA2 | 2.69239054 |
| 7 | MST4 | 2.67675075 |
| 8 | TESK1 | 2.48253490 |
| 9 | PIK3CA | 2.47720769 |
| 10 | NME2 | 2.44696505 |
| 11 | VRK2 | 2.31370856 |
| 12 | TRIB3 | 2.14515598 |
| 13 | PDK2 | 2.14432073 |
| 14 | PKN2 | 2.00003352 |
| 15 | MAP3K3 | 1.97174752 |
| 16 | STK38L | 1.94830774 |
| 17 | PRKG2 | 1.91992735 |
| 18 | TESK2 | 1.89130881 |
| 19 | MET | 1.84484008 |
| 20 | BUB1 | 1.80953726 |
| 21 | FRK | 1.78542922 |
| 22 | MAP3K12 | 1.77005975 |
| 23 | PASK | 1.75487044 |
| 24 | MAP3K11 | 1.68989074 |
| 25 | TAOK3 | 1.64859469 |
| 26 | MAP3K2 | 1.62264703 |
| 27 | PIM2 | 1.61450106 |
| 28 | BRSK2 | 1.61378663 |
| 29 | PTK6 | 1.54335730 |
| 30 | FLT3 | 1.53385323 |
| 31 | DDR2 | 1.52188455 |
| 32 | BRAF | 1.44084902 |
| 33 | SIK1 | 1.42131245 |
| 34 | PIK3CG | 1.41188846 |
| 35 | MAP2K1 | 1.39755033 |
| 36 | SMG1 | 1.38286739 |
| 37 | EIF2AK3 | 1.35191190 |
| 38 | LMTK2 | 1.32151193 |
| 39 | CCNB1 | 1.31468566 |
| 40 | KDR | 1.25953108 |
| 41 | NUAK1 | 1.24697728 |
| 42 | INSRR | 1.24093035 |
| 43 | RPS6KB2 | 1.22680337 |
| 44 | MAPKAPK3 | 1.20972259 |
| 45 | LIMK1 | 1.18653472 |
| 46 | KSR2 | 1.18552224 |
| 47 | ARAF | 1.15582420 |
| 48 | PTK2 | 1.13735389 |
| 49 | MAP3K8 | 1.12688455 |
| 50 | PRKCI | 1.05189457 |
| 51 | SRPK1 | 1.03074052 |
| 52 | EIF2AK1 | 1.02785727 |
| 53 | TSSK6 | 0.98496979 |
| 54 | ZAP70 | 0.96867217 |
| 55 | TAOK1 | 0.93098251 |
| 56 | EPHB2 | 0.88986161 |
| 57 | SCYL2 | 0.87727914 |
| 58 | DAPK1 | 0.87406672 |
| 59 | TAOK2 | 0.86745373 |
| 60 | CSNK1G3 | 0.84784095 |
| 61 | LRRK2 | 0.83130982 |
| 62 | MAP3K1 | 0.81711112 |
| 63 | MYLK | 0.80730478 |
| 64 | EPHA3 | 0.78924055 |
| 65 | NEK1 | 0.78046885 |
| 66 | GRK6 | 0.77002875 |
| 67 | WNK4 | 0.74228410 |
| 68 | STK16 | 0.72756318 |
| 69 | MAP3K10 | 0.72546436 |
| 70 | ERBB4 | 0.71396118 |
| 71 | CSNK1A1L | 0.69744196 |
| 72 | MAPK11 | 0.69085259 |
| 73 | FER | 0.68513178 |
| 74 | TLK1 | 0.68283662 |
| 75 | PBK | 0.68083739 |
| 76 | TRIM28 | 0.67774301 |
| 77 | PAK4 | 0.67214870 |
| 78 | CDK7 | 0.65252554 |
| 79 | SIK3 | 0.64332937 |
| 80 | CAMKK2 | 0.64027591 |
| 81 | BRSK1 | 0.63639307 |
| 82 | ICK | 0.63619685 |
| 83 | AURKB | 0.62762514 |
| 84 | CDC7 | 0.60813083 |
| 85 | TTK | 0.60760548 |
| 86 | PAK1 | 0.60245569 |
| 87 | STK10 | 0.59514646 |
| 88 | EEF2K | 0.57614374 |
| 89 | PLK4 | 0.56149368 |
| 90 | MAP2K6 | 0.55042662 |
| 91 | FGFR4 | 0.54118074 |
| 92 | AKT2 | 0.50066396 |
| 93 | RAF1 | 0.49214593 |
| 94 | MATK | 0.48096437 |
| 95 | VRK1 | 0.48058739 |
| 96 | BCR | 0.47465858 |
| 97 | BMX | 0.47111550 |
| 98 | RIPK1 | 0.45556321 |
| 99 | MAP2K7 | 0.45387765 |
| 100 | ILK | 0.44595090 |
| 101 | ABL2 | 0.44505006 |
| 102 | EPHB1 | 0.44439885 |
| 103 | CAMK2G | 0.43356933 |
| 104 | CHEK2 | 0.43217340 |
| 105 | WEE1 | 0.42377182 |
| 106 | NEK2 | 0.42321393 |
| 107 | ERBB2 | 0.42019476 |
| 108 | LATS1 | 0.41896293 |
| 109 | ZAK | 0.41676438 |
| 110 | MAPK15 | 0.41653422 |
| 111 | TBK1 | 0.40227100 |
| 112 | CDK8 | 0.40133613 |
| 113 | CSNK1G1 | 0.39287059 |
| 114 | MAP2K3 | 0.39154771 |
| 115 | NTRK1 | 0.38620686 |
| 116 | CDC42BPA | 0.38401726 |
| 117 | CDK9 | 0.38361625 |
| 118 | DAPK3 | 0.38024345 |
| 119 | ATR | 0.37030898 |
| 120 | CSNK1G2 | 0.36955685 |
| 121 | PDPK1 | 0.35831278 |
| 122 | TYK2 | 0.34541148 |
| 123 | PDGFRA | 0.34493169 |
| 124 | RPS6KA4 | 0.34421642 |
| 125 | IRAK3 | 0.33924302 |
| 126 | GRK1 | 0.33203842 |
| 127 | CSNK2A1 | 0.32289390 |
| 128 | TEC | 0.31427560 |
| 129 | CSNK2A2 | 0.29794306 |
| 130 | CAMK2D | 0.29786431 |
| 131 | AURKA | 0.29432357 |
| 132 | PRKD3 | 0.29209167 |
| 133 | MAP3K7 | 0.28698248 |
| 134 | CSNK1A1 | 0.27500679 |
| 135 | BLK | 0.27388938 |
| 136 | ACVR1B | 0.26822680 |
| 137 | CDK18 | 0.25682144 |
| 138 | PLK1 | 0.25501753 |
| 139 | CDK11A | 0.24430731 |
| 140 | CDK14 | 0.23355770 |
| 141 | DYRK1B | 0.22954696 |
| 142 | CDK15 | 0.21497187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.51165425 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.37979665 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.82662387 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.59639457 |
| 5 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.47327992 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.26545013 |
| 7 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.22687358 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.19081431 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.10549523 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.01440467 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.00500726 |
| 12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.94514046 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.94384575 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.92175790 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.86768735 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 1.86137998 |
| 17 | Sulfur relay system_Homo sapiens_hsa04122 | 1.74506266 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.73996733 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.71476061 |
| 20 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.66432531 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.65399402 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.59597790 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.58979646 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.54161616 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.48518102 |
| 26 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.46994112 |
| 27 | Proteasome_Homo sapiens_hsa03050 | 1.38151992 |
| 28 | * Galactose metabolism_Homo sapiens_hsa00052 | 1.36752307 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.34507737 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.34376464 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.32992885 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.32315794 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.31759237 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31538904 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31171944 |
| 36 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.31044680 |
| 37 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.30522287 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.30063092 |
| 39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.29942324 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.28872371 |
| 41 | Ribosome_Homo sapiens_hsa03010 | 1.26827290 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.26005495 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.22685534 |
| 44 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.22614465 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.21317317 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.18336945 |
| 47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.18003194 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.16862625 |
| 49 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.16581021 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.14316204 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12134333 |
| 52 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.09127870 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 1.07657474 |
| 54 | Parkinsons disease_Homo sapiens_hsa05012 | 1.07357165 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 1.06972768 |
| 56 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.06402139 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.04992053 |
| 58 | RNA polymerase_Homo sapiens_hsa03020 | 1.04509615 |
| 59 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.01143481 |
| 60 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.00886550 |
| 61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.00857738 |
| 62 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.99621937 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99515336 |
| 64 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.99371389 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.99237830 |
| 66 | Homologous recombination_Homo sapiens_hsa03440 | 0.95763368 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94876234 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94822548 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94733903 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93382399 |
| 71 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.90181702 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89869451 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89405671 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.88347597 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87503296 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.85681439 |
| 77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85036631 |
| 78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83481323 |
| 79 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.82200803 |
| 80 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75680500 |
| 81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74551132 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.73034561 |
| 83 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72630516 |
| 84 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.71888242 |
| 85 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.71077997 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.70471506 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.69989130 |
| 88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.68926826 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68088715 |
| 90 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67566800 |
| 91 | Spliceosome_Homo sapiens_hsa03040 | 0.66569599 |
| 92 | RNA transport_Homo sapiens_hsa03013 | 0.65515317 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.64252769 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.63015087 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.62831050 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61510549 |
| 97 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.58644459 |
| 98 | Purine metabolism_Homo sapiens_hsa00230 | 0.58296369 |
| 99 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56250612 |
| 100 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53916686 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53005100 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52007246 |
| 103 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51675565 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50562715 |
| 105 | Thyroid cancer_Homo sapiens_hsa05216 | 0.50155723 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48169645 |
| 107 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47534806 |
| 108 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.38461485 |
| 109 | DNA replication_Homo sapiens_hsa03030 | 0.38364978 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36743366 |
| 111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35942204 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34382331 |
| 113 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29727338 |
| 114 | Mismatch repair_Homo sapiens_hsa03430 | 0.28692168 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27960490 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.22124280 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22122532 |
| 118 | Legionellosis_Homo sapiens_hsa05134 | 0.21532942 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21287962 |

